Leo Buerger
Leo Buerger
| Birth date | September 13, 1879 |
|---|---|
| Birth place | Vienna, Austria |
| Died | October 6, 1943 |
| Place of death | New York City, USA |
| Nationality | American |
| Known for | Buerger's disease |
Leo Buerger (September 13, 1879 – October 6, 1943) was an American pathologist and surgeon renowned for his identification and description of Buerger's disease, also known as thromboangiitis obliterans.
Early Life and Education[edit | edit source]
Leo Buerger was born in Vienna, Austria, and immigrated to the United States with his family in 1889. He pursued his medical education at Columbia University, where he earned his medical degree in 1901.
Career[edit | edit source]
Buerger began his career at Mount Sinai Hospital in New York City, where he worked as a pathologist. His research focused on vascular diseases, and he made significant contributions to the understanding of thromboangiitis obliterans, a condition that primarily affects the small and medium-sized arteries and veins of the arms and legs.
Buerger's Disease[edit | edit source]
In 1908, Buerger published a seminal paper describing the clinical and pathological features of the disease that would later bear his name. Buerger's disease is characterized by inflammation and thrombosis (clotting) in the blood vessels, leading to reduced blood flow and tissue damage. It is strongly associated with tobacco use, and cessation of smoking is a critical component of treatment.
Legacy[edit | edit source]
Buerger's work laid the foundation for further research into vascular diseases and influenced the development of treatments for peripheral artery disease. His contributions to medical science are commemorated through the eponymous Buerger's disease.
Personal Life[edit | edit source]
Buerger was known for his dedication to medicine and his patients. He passed away in New York City in 1943.
See Also[edit | edit source]
References[edit | edit source]
- Buerger, L. (1908). "Thrombo-angiitis obliterans: A study of the vascular lesions leading to presenile spontaneous gangrene." American Journal of the Medical Sciences.
External Links[edit | edit source]
- [Mount Sinai Hospital Archives]
- [Columbia University Medical Center]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
